Event-Driven Stocks

APPLIED GENETIC TECHNOLOGIES CORP

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

Signs● 5 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY22FY21FY20FY19FY18FY17
Revenue$325,000$500,000$2.5M$2.5M$14.0M$10.3M
Operating income−$13.6M−$14.5M−$15.1M−$12.0M−$7.7M−$600,000
Net income−$14.3M−$14.9M−$15.4M−$11.6M−$8.1M−$1.2M
Total assets$66.7M$127.0M$100.3M$92.2M$118.5M$147.9M
Total liabilities$37.2M$41.2M$29.3M$13.5M$19.4M$32.6M
Equity$29.5M$85.8M$71.0M$78.7M$99.2M$115.3M
EPS (diluted)$-0.33$-0.40$-0.60$-0.64$-0.45$-0.07
Shares out.67.6M42.9M25.9M18.2M18.1M18.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2022
Operating margin
−4179.4%
Net margin
−4398.2%
Return on equity
−48.5%
Return on assets
−21.4%
Return on capital (ROCE)
−32.7%
Liabilities / assets
55.8%
Debt / equity
1.26×
Book value / share
$0.44
Revenue growth (YoY)
−35.0%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2022
Altman Z″ (distress)
-13.21distress
Accruals / assets
77.2%high accruals
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
22
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 0Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 5 warning● 0 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • High accruals — earnings-quality risk

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)